Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: Diclofenac induced gastrointestinal, liver, and encephalopathy lesions ScienceDirect BPC 157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven San Diego Orthobiologics Medical Group Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats: role of the nitric oxide system. Semantic Scholar BPC 157: The Promise and Perils of a Healing Peptide: Apple, Alex: 9798319471673: Amazon.com: Books